Findings
In this randomized clinical trial, 188 smokers chose between varenicline and nicotine patches and were then randomized to adaptive or standard treatment. Biochemically verified 30-day continuous smoking abstinence at 12 weeks after the target quit date was significantly higher for the adaptive treatment group than the standard treatment group.